Page 1 of Clinical Trials for Other Open label pharmacotherapy, 2108 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism
Last Updated: January 18, 2011
Condition(s): Major Depression
2
Active, not recruiting
Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers
Last Updated: September 23, 2011
Condition(s): Colorectal Cancer; Gastrointestinal Cancer
3
Recruiting
rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors
Last Updated: April 6, 2012
Condition(s): Advanced Oral and Maxillofacial Malignant Tumors
4
Active, not recruiting
Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer
Last Updated: April 6, 2012
Condition(s): Adenocarcinoma of the Prostate
5
Completed
AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Last Updated: January 18, 2011
Condition(s): Colorectal Cancer; Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
6
Active, not recruiting
A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab
Last Updated: September 1, 2011
Condition(s): Non-Small Cell Lung Cancer
7
Recruiting
This Trial is a Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
Last Updated: May 15, 2012
Condition(s): Primary Mediastinal B-cell Lymphoma
8
Completed
Phase II Trial Evaluating the Efficacy and Tolerability of Aprepitant & Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting
Last Updated: December 12, 2011
Condition(s): Colorectal Cancer; Nausea and Vomiting
9
Recruiting
Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment.
Last Updated: February 4, 2011
Condition(s): BRMS1; Performance Status Zero to Two for Beginning the Study; Patient With a Maximum of One Chemotherapy; Patient With Progression After Taxanes
10
Active, not recruiting
A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Patients With Lung Cancer Who Have Not Received Chemotherapy Before
Last Updated: January 11, 2012
Condition(s): Non-Small Cell Lung Cancer
11
Recruiting
Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide
Last Updated: February 28, 2012
Condition(s): Soft Tissue Sarcoma
12
Not yet recruiting
An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
Last Updated: April 25, 2012
Condition(s): Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction
13
Not yet recruiting
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma
Last Updated: July 7, 2009
Condition(s): Lymphoma
14
Not yet recruiting
A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer
Last Updated: April 25, 2012
Condition(s): Metastatic Pancreas Cancer
15
Recruiting
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
Last Updated: August 5, 2011
Condition(s): Colorectal Cancer; Metastatic Cancer
16
Recruiting
A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
Last Updated: May 3, 2012
Condition(s): Small Cell Lung Carcinoma
17
Recruiting
Optimizing Pharmacotherapy for Bipolar Alcoholics
Last Updated: November 20, 2009
Condition(s): Bipolar Disorder; Alcohol Dependence
18
Completed
Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy
Last Updated: February 20, 2008
Condition(s): Cancer; Non-Myeloid Malignancies
19
Recruiting
S-1 and Photodynamic Therapy in Cholangiocarcinoma
Last Updated: March 26, 2009
Condition(s): Cholangiocarcinoma
20
Terminated
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
Last Updated: February 9, 2012
Condition(s): Fatigue; Chemotherapy Side Effects

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Other+Open+label+pharmacotherapy

Page 1 of Clinical Trials for Other Open label pharmacotherapy, 2108 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About